ALLO Allogene Therapeutics Inc

$ALLO Nice plug from Fox Business News! There guest on Making Money just had a large shoutout for ALLO. Stocks is not reacting, but he was very high on there technology! You don't see Analyst recommending $2 stocks very often!

$ALLO (1178) Preliminary Safety and Efficacy Results From a First-in-Human Phase 1 Clinical Study of ALLO-329, a Dual Anti-CD19/Anti-CD70 Allogeneic CAR T-Cell Therapy for Autoimmune Disease Monday, November 9, 2026 10:30 AM - 12:30 PM East Coast USA Time

$ALLO The more you look at this exceptional SSc patient from the ALLO-329 RESOLUTION trial abstract 1178 from ACR Convergence 2026, the more important the result becomes. This was progressive, treatment-refractory diffuse systemic sclerosis - a serious, high-mortality autoimmune disease - yet at only 40M ALLO-329 cells + cyclophosphamide, her mRSS dropped from 19 to 6 in just 3 months. Every time you put this patient into the proper disease context, the result tells us something important. It is still early and we need more patients and follow-up, but a 13-point reduction in clinically assessed skin thickness in progressive dcSSc deserves attention. This is one of the hardest autoimmune diseases to treat. This graphic below puts that result into perspective.

$ALLO ALLO-329, Autoimmune, Immune reset, No Chemo. Major disruption took place in the first 14 days in the exceptional SSc patient discussed in abstract 1178. The image below shows this disruption and then the values keep going down as time moves forward. Remember if those bad T helper cells have been dismantled, it will take about six months for that network to come back. That network should come back to a balanced system and be healthy. Note: If this was a CD19 only CAR-T therapy, persistence is required because the T-helper network gets starved out by the B cells being suppressed. ALLO-329 targets them immediately when infused into the body.

$ALLO if 329 is positive then we go to 75. It could be a bargain of the century at 1.60. Keep moving down so I can buy more! With others failing Allo technology could be te real deal. With no ichans or CRS the big boys could be knocking on their doors if trials succeed!

$ALLO I just entered. I think at some point this thing will bounce back. Whether that's this week or next year, I wish I knew. In for the long haul.

$ALLO Short interest 118 mn as of August 31, 2026. We just need one piece of good news to send this thing not to the Moon, but straight to Mars!

$ALLO Holy F$&$ this really went green on Friday? Breaks a string of 12 straight days red. Did 10M in volume. Hmm

$ALLO Updated image of earlier image from previous post. ALLO-329 starts working on both sides of the pathogenic loops to disrupt the pathogenic network faster and deeper.

$ALLO just posted fullninterview on fox, high expectations for ALLO towards the end of this year.

$ALLO 🔥 ALLO-329 ACR abstract is now public and the early data are VERY encouraging • 9 patients treated • No DLTs • Only 1 Grade-1 CRS • B-cell suppression demonstrated • Activity at low doses • Activity even without conventional cyclophosphamide lymphodepletion 🔥 Standout result: systemic-sclerosis patient mRSS 19 → 6 at Month 3. Several individual areas reached 0, including upper arm by Day 14 and foot by Day 28. This could be a major validation signal for Allogene’s Dagger platform and the potential for off-the-shelf CAR-T with reduced/no traditional lymphodepletion. 📅 ALLO-329 ACR pres: Nov 9 🔥 TPG overhang is also GONE. TPG sold its entire 18.7M-share position at $1.55 (~$29M). Zero shares remaining. Meanwhile, ALLO has ~$424M cash/investments and runway into Q1 2029. So we have: ✅ ALLO-329 clinical activity ✅ Clean safety so far ✅ Dagger differentiation ✅ Huge cash runway ✅ TPG selling pressure finished ✅ November catalyst ✅ ALPHA3 ahead ✅ Significant short interest

$ALLO for ALLO to be mentioned on FOX business I believe something is brewing. I bought more this morning I’ll keep adding in case it keep dropping

$ALLO Kevin Mahn was on the Schwab Network shilling for #ALLO again today. What's with this guy? Interview was on LinkedIn and ALLO liked it.... Hmmm

$ALLO On August 11, 2026, I posted that instructional holding stood at 61%. As of today, it has risen to 84.22%. Something for shorting enthusiasts to consider!

$ALLO Likely, it will slowly (and painfully) grind its way up to 2.0 before the next cycle of shorting starts; or, sky rocket based on the November announcement. Let’s see.

$ALLO Boy they love posting on LinkedIn. I guess it's that until results in November. This is painful to watch

$ALLO The Company had $423.6 million in cash, cash equivalents, and investments as of June 30, 2026. Based on its cash, cash equivalents, and investments as of June 30, 2026, the Company currently projects its cash runway into 2029

$ALLO unbelievable how much pathetic Volume is a joke, nobody is buying and shorts are partying It can’t even move on a fckn green bio day

$ALLO Glad to have even a modest position in this. Nice bounce off recent support levels.

$ALLO serious Q - is car-t still relevant? It was the craze back w/ KITE, BLUE, JUNO like in 2016-2017. Now a days theres "cancer vaccines", gene editing and a bunch of other stuff I have no clue about. Tldr, is there a light at the end of this tunnel?